On ECHEMI
Home > Drugs > KPC Pharmaceuticals, Inc.
KPC Pharmaceuticals, Inc.
  • Founded in:

    1995-12-14
  • Country:

    China China
  • Address:

    No. 166, Keyi Road, High-tech Industrial Development Zone, Kunming, Yunnan Province
  • Tax NO.:

    91530000216562280W
  • Registered Funds:

    757.986969 yuan
  • Website:

  • Email:

Related Drugs
Ethyl polyenoate soft capsules
pentosapentaenoic acid.
Name Description Content CAS NO. Registered Holders
EPA

It has significant physiological activity in lowering serum triglycerides and total cholesterol, increasing high-density lipoprotein cholesterol, inhibiting platelet aggregation and delaying thrombosis.

More

It has significant physiological activity in lowering serum triglycerides and total cholesterol, increasing high-density lipoprotein cholesterol, inhibiting platelet aggregation and delaying thrombosis.

10417-94-4 0
Ethyl polyenoate soft capsules
pentosapentaenoic acid.
Name Description Content CAS NO. Registered Holders
EPA

It has significant physiological activity in lowering serum triglycerides and total cholesterol, increasing high-density lipoprotein cholesterol, inhibiting platelet aggregation and delaying thrombosis.

More

It has significant physiological activity in lowering serum triglycerides and total cholesterol, increasing high-density lipoprotein cholesterol, inhibiting platelet aggregation and delaying thrombosis.

10417-94-4 0
Ethyl polyacrylate capsules
pentosapentaenoic acid.
Name Description Content CAS NO. Registered Holders
EPA

Lower serum triglycerides and total cholesterol, increase high-density lipoprotein cholesterol, inhibit platelet aggregation and delay thrombosis

More

Lower serum triglycerides and total cholesterol, increase high-density lipoprotein cholesterol, inhibit platelet aggregation and delay thrombosis

10417-94-4 0
Ethyl polyacrylate capsules
pentosapentaenoic acid.
Name Description Content CAS NO. Registered Holders
EPA

It has significant physiological activity in lowering serum triglycerides and total cholesterol, increasing high-density lipoprotein cholesterol, inhibiting platelet aggregation and delaying thrombosis.

More

It has significant physiological activity in lowering serum triglycerides and total cholesterol, increasing high-density lipoprotein cholesterol, inhibiting platelet aggregation and delaying thrombosis.

10417-94-4 0
Bismuth Potassium Citrate
Name Description Content CAS NO. Registered Holders
BISMUTH POTASSIUM CITRATE

Unspecified

More

Unspecified

57644-54-9 18
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.